Vor Biopharma Inc. — Director's Dealing 2021

Feb 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-02-04

Reporting Person: Slapak Christopher (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$1.90	2030-08-24	Common Stock (153119)		Direct
Employee Stock Option (right to buy)	$1.90	2030-08-20	Common Stock (153088)		Direct

Footnotes

F1: 1/4th of the shares underlying the option vest on July 30, 2020, with the remainder vesting in equal monthly installments over 3 years, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.

F2: 1/48th of the shares underlying the option vest or vested in equal monthly installments commencing on September 1, 2020, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.